C3 Jian, Inc. Appoints Vice President Product Development

LOS ANGELES, March 1, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that Brian C. Varnum, Ph.D., has been appointed Vice President of Product Development, effective immediately. Dr. Varnum will be responsible for the commercial development of the Company's lead products, with particular focus on C3 Jian's C16G2, a therapeutic peptide targeting dental caries. The Company expects in April to file an Investigational New Drug application with the U.S. Food and Drug Administration to begin human clinical trials of the C16G2 peptide. Dr. Varnum will lead the Company's efforts to coordinate commercial activities as its products move from research to development. Dr. Varnum brings 23 years of product development experience to C3 Jian, covering all areas of commercialization from research to product launch. Dr. Varnum is C3 Jian's first Vice President of Product Development.

Back to news